Product NDC: | 55390-481 |
Proprietary Name: | Ketorolac Tromethamine |
Non Proprietary Name: | Ketorolac Tromethamine |
Active Ingredient(s): | 30 mg/mL & nbsp; Ketorolac Tromethamine |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55390-481 |
Labeler Name: | Bedford Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075222 |
Marketing Category: | ANDA |
Start Marketing Date: | 19990426 |
Package NDC: | 55390-481-02 |
Package Description: | 10 VIAL in 1 BOX (55390-481-02) > 2 mL in 1 VIAL |
NDC Code | 55390-481-02 |
Proprietary Name | Ketorolac Tromethamine |
Package Description | 10 VIAL in 1 BOX (55390-481-02) > 2 mL in 1 VIAL |
Product NDC | 55390-481 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Ketorolac Tromethamine |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 19990426 |
Marketing Category Name | ANDA |
Labeler Name | Bedford Laboratories |
Substance Name | KETOROLAC TROMETHAMINE |
Strength Number | 30 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |